Author: No Change Reviewer: No Change Primary Changes: Added Key Takeaways feature
J., D Seeger, J., Zhou, L., Ng, E., Ross, D., Major-Pedersen, A., Bosch-Traberg, H., Gydesen, H., & Dore, D
Any decision to initiate or continue GLP-1 therapy should be based on licensed indications and NICE-approved criteria, considering your individual metabolic health needs and treatment goals
They may offer a meaningful reduction in cravings and relapse risk across various addictive disorders." Dr Sophie Dix, Head of Medical Product and Content at Levity "GLP-1s appear to modulate activity in the mesolimbic dopamine system, the same circuitry implicated in both substance addiction and compulsive overeating
Estrogen is diminished